[go: up one dir, main page]

ES2064856T3 - Composiciones farmaceuticas que contienen compuestos triciclicos. - Google Patents

Composiciones farmaceuticas que contienen compuestos triciclicos.

Info

Publication number
ES2064856T3
ES2064856T3 ES91118592T ES91118592T ES2064856T3 ES 2064856 T3 ES2064856 T3 ES 2064856T3 ES 91118592 T ES91118592 T ES 91118592T ES 91118592 T ES91118592 T ES 91118592T ES 2064856 T3 ES2064856 T3 ES 2064856T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
compositions containing
tricyclic compounds
containing tricyclic
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91118592T
Other languages
English (en)
Inventor
Sotoo Asakura
Michiyo Fukae
Shigeo Nakanishi
Yasuto Koyama
Youhei Kiyota
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2064856T3 publication Critical patent/ES2064856T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

UN COMPUESTO FARMACEUTICO, EN EMULSION O EN SOLUCION, EN UN DISOLVENTE ORGANICO CONTIENE UNA PREPARACION REPRESENTADA POR LA SIGUIENTE FORMULA, CON ACTIVIDAD INMUNOREPRESORA, QUE ES REVELADA AQUI:
ES91118592T 1990-11-02 1991-10-31 Composiciones farmaceuticas que contienen compuestos triciclicos. Expired - Lifetime ES2064856T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29813590 1990-11-02
JP29813690 1990-11-02

Publications (1)

Publication Number Publication Date
ES2064856T3 true ES2064856T3 (es) 1995-02-01

Family

ID=26561392

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91118592T Expired - Lifetime ES2064856T3 (es) 1990-11-02 1991-10-31 Composiciones farmaceuticas que contienen compuestos triciclicos.

Country Status (17)

Country Link
US (1) US5955469A (es)
EP (1) EP0483842B1 (es)
JP (1) JPH059117A (es)
KR (1) KR100206722B1 (es)
CN (1) CN1069194C (es)
AT (1) ATE115400T1 (es)
AU (1) AU655603B2 (es)
CA (1) CA2054629C (es)
DE (1) DE69105915T2 (es)
DK (1) DK0483842T3 (es)
ES (1) ES2064856T3 (es)
HU (1) HU217540B (es)
IE (1) IE66592B1 (es)
PH (1) PH31204A (es)
PT (1) PT99398B (es)
RU (1) RU2084222C1 (es)
UA (1) UA43820C2 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0689426B1 (en) * 1993-03-22 2000-05-17 Betatene Pty. Ltd. Therapeutic agent for the treatment of melanomas
JPH08510995A (ja) * 1993-03-22 1996-11-19 ベータティーン・リミテッド 水分散性治療用化合物
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
DE4447972B4 (de) * 1993-05-27 2007-12-27 Novartis Ag Galenische Formulierungen
AT408520B (de) * 1993-05-27 2001-12-27 Novartis Erfind Verwalt Gmbh Galenische formulierungen
GB2315216B (en) * 1993-10-05 1998-10-14 Ciba Geigy Ag Microemulsion preconcentrates comprising FK506 or 33-epi-chloro-33-desoxy-ascomycin
GB2308546B (en) * 1994-10-26 1999-06-02 Novartis Ag Topical macrolide compositions
PT851753E (pt) 1995-09-19 2004-04-30 Fujisawa Pharmaceutical Co Composicoes em aerossol
IL155065A (en) * 1997-04-04 2004-01-04 Mitsubishi Pharma Corp History - 2 Aminopropene - 1, 3 - Diol and Pharmaceutical Preparations Containing Them
KR100406823B1 (ko) * 1998-04-27 2003-11-21 후지사와 야꾸힝 고교 가부시키가이샤 의약 조성물
US6864232B1 (en) 1998-12-24 2005-03-08 Sucampo Ag Agent for treating visual cell function disorder
GB0108498D0 (en) * 2001-04-04 2001-05-23 Novartis Ag Organic Compounds
AR038628A1 (es) * 2002-03-04 2005-01-19 Novartis Ag Composicion oftalmica
JP2005230125A (ja) 2004-02-17 2005-09-02 Aruze Corp ゲーム装置及びゲームプログラム
KR100866728B1 (ko) * 2004-11-12 2008-11-03 주식회사종근당 타크로리무스를 함유하는 주사제
CN101869547B (zh) 2009-04-24 2012-02-22 张娜 一种他克莫司注射制剂
KR101230573B1 (ko) * 2010-04-21 2013-02-06 닥터후 주식회사 천년초 추출물 또는 백년초 추출물을 함유하는 천연 유화제 및 이를 포함하는 화장품 조성물, 식품 조성물 및 의약 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
GB2212061B (en) * 1987-11-09 1991-08-28 Sandoz Ltd Topical compositions comprising 11,28-dioxa-4-azatricyclo [22.3.1.0(4,9)] octacos-18-ene derivatives
EP0346427B1 (en) * 1987-12-09 1995-03-29 FISONS plc Macrocyclic compounds
EP0356399A3 (en) * 1988-08-26 1991-03-20 Sandoz Ag Substituted 4-azatricyclo (22.3.1.04.9) octacos-18-ene derivatives, their preparation and pharmaceutical compositions containing them
GB8925797D0 (en) * 1989-11-15 1990-01-04 Fisons Plc Compositions
US5260301A (en) * 1990-03-01 1993-11-09 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical solution containing FK-506

Also Published As

Publication number Publication date
AU655603B2 (en) 1995-01-05
EP0483842B1 (en) 1994-12-14
IE913813A1 (en) 1992-05-22
IE66592B1 (en) 1996-01-24
ATE115400T1 (de) 1994-12-15
KR100206722B1 (ko) 1999-07-01
DK0483842T3 (da) 1995-02-20
RU2084222C1 (ru) 1997-07-20
DE69105915D1 (de) 1995-01-26
KR920009400A (ko) 1992-06-25
US5955469A (en) 1999-09-21
JPH059117A (ja) 1993-01-19
PH31204A (en) 1998-05-05
HU217540B (hu) 2000-02-28
CN1061153A (zh) 1992-05-20
DE69105915T2 (de) 1995-05-04
CA2054629C (en) 2002-04-16
HUT60924A (en) 1992-11-30
EP0483842A1 (en) 1992-05-06
PT99398B (pt) 1999-04-30
HU343891D0 (en) 1992-01-28
PT99398A (pt) 1992-09-30
CN1069194C (zh) 2001-08-08
AU8692291A (en) 1992-05-07
CA2054629A1 (en) 1992-05-03
UA43820C2 (uk) 2002-01-15

Similar Documents

Publication Publication Date Title
ES2064856T3 (es) Composiciones farmaceuticas que contienen compuestos triciclicos.
NO904377L (no) Tricykliske karbapenemforbindelser.
DE59204094D1 (de) Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel als Antikoagulantien.
ATE119774T1 (de) Imidazopyridinderivate und ihre verwendung.
ATE157089T1 (de) Derivate von alkanolaminen als kardiovaskuläre mittel
ES2104090T3 (es) Nuevas 3',5'-di-t-butil-4'-hidroxi-flavonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
BR9201854A (pt) Composto derivado de pridazinas,processo para sua preparacao,e,composicao farmaceutica
ATE144498T1 (de) Herstellung von substituierten piperidinen
ES2161713T3 (es) Derivado de metotrexato.
ATE205469T1 (de) Phenylbenzoesäureester-derivate und flüssigkristallzubereitungen
ES2091310T3 (es) Nuevos derivados de la n-benzoil-prolina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DE69309559D1 (de) Fungizide Phenylbenzamid derivate
GB1476720A (en) Substituted cyclohexanes
DE69121259D1 (de) Beta-Lactam-Verbindungen und ihre Herstellung
DE3879258D1 (de) Praeparat gegen ulcus.
DE69424734D1 (de) Phenyl-Carboxamide-Isoxazole-Derivate und Salze, Verfahren zu ihrer Herstellung ihre Anwendung als Arzneimittel und pharmazeutische Zusammensetzungen die sie enthalten
SE8300452D0 (sv) Perfluorobicyklo-foreningar och emulsionspreparat innehallande foreningen
ATE170862T1 (de) 5-ht3 pyrrolopyrazinderivate
ATE5408T1 (de) Cephalosporine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
NO303817B1 (no) Tiokarbamatsulfoksydsammensetning for avholdenhet fra inntakelse av etanol
KR960705101A (ko) 비스스티릴 화합물을 기초로 하는 증백제 혼합물(brightening mixtures based on bistyryl compounds)
DK0576330T3 (da) Fremgangsmåde til fremstilling af delta-9(11)-steroidforbindelser
ATE92919T1 (de) Heterocyclische phenylaether, verfahren zu deren herstellung und diese enthaltende herbizide mittel.
KR920002613A (ko) 이환성 함유 황화합물
ATE117682T1 (de) Substituierte benzothiazolinone, ihre herstellung und sie enthaltende pharmazeutische zusammenstellungen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 483842

Country of ref document: ES